Medicina
Departamento
Marmara University
Estambul, TurquíaPublicaciones en colaboración con investigadores/as de Marmara University (6)
2024
-
Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?
Arthritis Care and Research, Vol. 76, Núm. 1, pp. 88-97
2022
-
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey
Blood, Vol. 140, Núm. 26, pp. 2773-2787
2021
-
PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis
Journal of Hepatology, Vol. 74, Núm. 5, pp. 1097-1108
2020
-
The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology
Journal of Hepatology, Vol. 73, Núm. 4, pp. 842-854
2019
-
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: A European Scleroderma Trials and Research (EUSTAR) analysis
Annals of the Rheumatic Diseases, Vol. 78, Núm. 9, pp. 1242-1248
-
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the european scleroderma trials and research (eustar) cohort
Annals of the Rheumatic Diseases, Vol. 78, Núm. 5, pp. 648-656